Skip to main content

Advertisement

Table 2 The electrocardiographic parameters

From: The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

  WKY (n = 9) SHR (n = 7) EMPA (n = 7) P value (ANOVA)
RR (ms) 201.6 ± 26.5 178.7 ± 18.6 193.8 ± 20.4 0.1862
P width (μs) 20.1 ± 1.24 20.8 ± 0.43 19.6 ± 1.7 0.2930
PR (μs) 54.3 ± 4.5 60.3 ± 3.0 59.2 ± 6.4 0.0710
QRS (μs) 30.2 ± 2.3 34.3 ± 5.1 34.5 ± 5.2 0.0923
QT (μs) 109.4 ± 27.0 91.7 ± 7.9 98.3 ± 8.4 0.2028
QTc (μs) 161.2 ± 20.3 154.6 ± 12.2 152.7 ± 9.4 0.5212
  1. Data are presented as mean ± standard deviation
  2. With Tukey’s multiple comparison test